Hassabis steps back from DeepMind: what it means for the UK's flagship lab
Demis Hassabis, the co-founder and public face of Google DeepMind, is stepping back from running it. Announced in early August, the change makes Hassabis chair of Google DeepMind and chief scientist of Alphabet, while he continues to lead Isomorphic Labs, the drug-discovery company spun out of DeepMind’s protein-structure work. Day-to-day leadership of the lab passes to Koray Kavukcuoglu, a thirteen-year DeepMind veteran and its former chief technology officer, who takes the role as a senior vice-president reporting directly to Google’s chief executive, Sundar Pichai.
Because DeepMind is headquartered in London and is the single most important anchor of the UK’s AI ecosystem, a change at its top is a UK story, not just a Google one.
What is actually changing
Kavukcuoglu is not an outside hire parachuted in. He joined DeepMind in its early days, started its deep-learning team, and led work behind landmark systems including WaveNet and DQN; by many accounts he had already been steering Gemini for some time. He now oversees Gemini model development, frontier AI research, and the Gemini app and developer teams — effectively consolidating DeepMind’s research and Google’s flagship product line under one leader who reports into the top of Google.
The move comes against an uncomfortable backdrop. Reporting around the change has pointed to delays on Gemini, intense competitive pressure, and a run of senior departures — Jeff Dean, Google’s long-serving head of AI, is also said to be leaving. Whatever the internal detail, the shape of it is a lab being pulled tighter into the cadence of a product company.
Why it cuts both ways for the UK
There is reassurance in it. Hassabis is not leaving; he stays UK-based as chair and Alphabet’s chief scientist, and he keeps running Isomorphic Labs, one of the most ambitious science-AI bets in the country. The gravitational pull DeepMind exerts on UK talent — the reason so many British AI founders trace back to it — does not switch off because the CEO changed hats.
But there is something to watch. A DeepMind organised around Gemini and reporting to Pichai is a DeepMind pulled further into Google’s product machine and, arguably, a little further from the open-ended London research lab that made its name on AGI-scale science like AlphaFold. For the UK, DeepMind has always been valuable precisely as a world-class research institution on British soil. If its centre of gravity shifts toward shipping product from Mountain View, the question is what that means for the research culture, and the talent, that the rest of the UK ecosystem quietly depends on. None of that is decided yet — but it is worth following, because when the anchor moves, the whole harbour feels it.
Read the original story on Google .
Companies in this story
- Google DeepMind Runs one of the world's leading AI research labs, behind breakthroughs including AlphaFold, AlphaGo, and the Gemini family of models. Headquartered in London and part of Google, it anchors much of the UK's AI research base.
- Isomorphic Labs Applies AI to drug discovery, using models descended from AlphaFold to predict how molecules behave and design new medicines. Headquartered in London as an Alphabet company spun out of DeepMind.
Previous coverage
- Isomorphic Labs raises $2.1B to turn AlphaFold into medicines 12 May 2026
- AI took more than 70% of UK venture funding in the first half of 2026 7 August 2026
- UK's Sovereign AI fund now backs 12 companies, and wants to be their customer 20 August 2026
- UK AI Security Institute launches Control Red Team, finds flaws in every safety monitor it tested at Anthropic and DeepMind 24 July 2026
- CloudNC raises $20M to point AI at the factory floor 10 September 2026